$JXN
Jackson Financial Inc. Stock $jxn

$jxn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000182299324000009 Filed on February 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	-$322.0M	$892.0M	$3.159B
YoY Change	-103.26%	-334.12%	-78.29%
Cost Of Revenue			$965.0M
YoY Change			-57.86%
Gross Profit			$2.194B
YoY Change			-82.11%
Gross Profit Margin			69.45%
Selling, General & Admin	$1.106B	$281.0M	$1.145B
YoY Change	8.22%	-71.82%	-70.81%
% of Gross Profit			52.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	-$1.250B	$2.812B	$2.016B
YoY Change	-199.05%	428.57%	-72.49%
Operating Profit			$178.0M
YoY Change			-96.39%
Interest Expense	$25.00M	-$35.00M	$185.0M
YoY Change	-41.86%	-12.5%	63.72%
% of Operating Profit			103.93%
Other Income/Expense, Net
YoY Change
Pretax Income	$903.0M	-$1.955B	$958.0M
YoY Change	-88.32%	105.14%	-86.53%
Income Tax	$101.0M	-$395.0M	$4.000M
% Of Pretax Income	11.18%		0.42%
Net Earnings	$795.0M	-$1.570B	$934.0M
YoY Change	-87.15%	121.13%	-83.61%
Net Earnings / Revenue		-176.01%	29.57%
Basic Earnings Per Share	$10.04		$10.99
Diluted Earnings Per Share	$9.94	-$19.45	$10.76
COMMON SHARES
Basic Shares Outstanding	77.41M shares	79.50M shares	81.80M shares
Diluted Shares Outstanding	78.87M shares		83.58M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.542B	$2.688B	$2.688B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$68.11B	$67.35B	$67.35B
YoY Change	3.46%	4.14%	4.14%
Other Assets	$749.0M	$640.0M	$640.0M
YoY Change	-0.79%	66.23%	66.23%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$340.3B	$330.3B	$330.3B
YoY Change	8.03%	6.17%	6.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$970.0M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$92.00M	$780.0M	$780.0M
YoY Change	-83.12%	13.21%	13.21%
LONG-TERM LIABILITIES
Long-Term Debt	$2.033B	$2.037B	$2.037B
YoY Change	-22.76%	-22.69%	-22.69%
Other Long-Term Liabilities	$9.480B	$10.26B	$10.26B
YoY Change	56.62%	65.48%	65.48%
Total Long-Term Liabilities	$11.51B	$12.30B	$12.30B
YoY Change	32.56%	39.19%	39.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$92.00M	$780.0M	$780.0M
Total Long-Term Liabilities	$11.51B	$12.30B	$12.30B
Total Liabilities	$329.9B	$319.9B	$320.1B
YoY Change	7.96%	5.97%	5.77%
SHAREHOLDERS EQUITY
Retained Earnings	$7.766B	$7.038B
YoY Change	21.29%	-15.03%
Common Stock	$1.000M	$1.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.17B	$10.17B	$10.17B
YoY Change
Total Liabilities & Shareholders Equity	$340.3B	$330.3B	$330.3B
YoY Change	8.03%	6.17%	6.17%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$795.0M	-$1.570B	$934.0M
YoY Change	-87.15%	121.13%	-83.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$1.426B	$1.634B	$5.310B
YoY Change	-72.61%	-27.86%	2.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$73.00M	$93.00M	-$623.0M
YoY Change	-125.89%	-102.42%	-281.63%
Cash From Investing Activities	-$2.006B	$93.00M	-$592.0M
YoY Change	-30.4%	-102.42%	-56.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$306.0M
YoY Change			-4.67%
Debt Paid & Issued, Net	$345.0M		$351.0M
YoY Change
Cash From Financing Activities	$433.0M	-1.801B	-$6.328B
YoY Change	-139.4%	-434.76%	192.69%
NET CHANGE
Cash From Operating Activities	$1.426B	1.634B	$5.310B
Cash From Investing Activities	-$2.006B	93.00M	-$592.0M
Cash From Financing Activities	$433.0M	-1.801B	-$6.328B
Net Change In Cash	-$147.0M	-74.00M	-$1.610B
YoY Change	-94.17%	-92.88%	-196.41%
FREE CASH FLOW
Cash From Operating Activities	$1.426B	$1.634B	$5.310B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-5864000000	usd
CY2023	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	-1801000000	usd
CY2022	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	2186000000	usd
CY2023	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-7665000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-837000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-5365000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	21000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2022	us-gaap	Other Income OtherIncome	85000000	usd
CY2021	us-gaap	Other Income OtherIncome	94000000	usd
CY2022	us-gaap	Revenues Revenues	9863000000	usd
CY2021	us-gaap	Revenues Revenues	6360000000	usd
CY2021	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	925000000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001822993
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40274
CY2023	dei	Entity Registrant Name EntityRegistrantName	Jackson Financial Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0486152
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Corporate Way
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Lansing
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48951
CY2023	dei	City Area Code CityAreaCode	517
CY2023	dei	Local Phone Number LocalPhoneNumber	381-5500
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2500000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	77412271	shares
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Chicago, IL
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	21000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	44844000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	48798000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	40422000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	42489000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	2153000000	usd
CY2022Q4	jxn	Debt Securities Fair Value Option DebtSecuritiesFairValueOption	2173000000	usd
CY2023Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	68000000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	100000000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	394000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	165000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10082000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	10967000000	usd
CY2023Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	481000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3457000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	390000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	2466000000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	3595000000	usd
CY2023Q4	us-gaap	Investments Investments	60855000000	usd
CY2022Q4	us-gaap	Investments Investments	65946000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2688000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298000000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	512000000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	514000000	usd
CY2023Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12302000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12923000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	29000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	25422000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	149000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	6737000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	640000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	320000000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1294000000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	944000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2023Q4	us-gaap	Assets Assets	330255000000	usd
CY2022Q4	us-gaap	Assets Assets	314983000000	usd
CY2023Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	11898000000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	55319000000	usd
CY2022Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	4785000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3626000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Fair Value Option FundsHeldUnderReinsuranceAgreementsFairValueOption	3582000000	usd
CY2023Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	19952000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2037000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2023Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	19000000	usd
CY2022Q4	jxn	Securities Sold Under Agreements To Repurchase And Securities Loaned SecuritiesSoldUnderAgreementsToRepurchaseAndSecuritiesLoaned	1048000000	usd
CY2023Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	780000000	usd
CY2022Q4	us-gaap	Obligation To Return Securities Received As Collateral ObligationToReturnSecuritiesReceivedAsCollateral	689000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1210000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2023Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219656000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	319921000000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	305605000000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	24000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	22000	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	533000000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78660221	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78660221	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82690098	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6005000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6063000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	15820785	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	11784813	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	599000000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	443000000	usd
CY2023Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	-178000000	usd
CY2022Q4	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	-66000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2808000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3378000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7038000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6403000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10170000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8646000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	164000000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	732000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10334000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	330255000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314983000000	usd
CY2021	us-gaap	Fee Income FeeIncome	8059000000	usd
CY2023	jxn	Net Investment Income Funds Withheld Assets NetInvestmentIncomeFundsWithheldAssets	1174000000	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	2930000000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	2761000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-3023000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-5344000000	usd
CY2021	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	-21000000	usd
CY2023	us-gaap	Other Income OtherIncome	67000000	usd
CY2023	us-gaap	Revenues Revenues	3159000000	usd
CY2023	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	965000000	usd
CY2022	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	1062000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-102000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	34000000	usd
CY2021	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-41000000	usd
CY2023	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3897000000	usd
CY2022	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3536000000	usd
CY2021	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3966000000	usd
CY2023	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	1145000000	usd
CY2022	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	866000000	usd
CY2021	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	832000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	185000000	usd
CY2022	us-gaap	Interest Expense InterestExpense	113000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	37000000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	2549000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2432000000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2839000000	usd
CY2023	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	1152000000	usd
CY2022	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	1226000000	usd
CY2021	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	1307000000	usd
CY2023	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2201000000	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2129000000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2015000000	usd
CY2023	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	958000000	usd
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	7734000000	usd
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	4345000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1505000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	666000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	954000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	20000000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43000000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	262000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	934000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6186000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3417000000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	899000000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	899000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6186000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6186000000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3417000000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3417000000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.99
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	72.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	36.35
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	69.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	36.17
CY2023	us-gaap	Profit Loss ProfitLoss	954000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	201000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-917000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-594000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1697000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7507000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2144000000	usd
CY2023	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	-7000000	usd
CY2022	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	-1000000	usd
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	1000000	usd
CY2023	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-26000000	usd
CY2022	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-2000000	usd
CY2021	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	3000000	usd
CY2023	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	-41000000	usd
CY2022	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	361000000	usd
CY2021	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	110000000	usd
CY2023	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	-146000000	usd
CY2022	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	1303000000	usd
CY2021	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	397000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-265000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	407000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-92000000	usd
CY2023	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	-955000000	usd
CY2022	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	1468000000	usd
CY2021	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	-332000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	570000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4738000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2076000000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1524000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1491000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1603000000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	20000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	43000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	262000000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1504000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1448000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1341000000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9923000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2076000000	usd
CY2021	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-76000000	usd
CY2021	us-gaap	Dividends Dividends	50000000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	211000000	usd
CY2021	jxn	Stock Issued During Period Value Demerger StockIssuedDuringPeriodValueDemerger	5000000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	123000000	usd
CY2021	jxn	Equity Compensation Reserve Period Increase Decrease EquityCompensationReservePeriodIncreaseDecrease	-8000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8321000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4738000000	usd
CY2022	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	9000000	usd
CY2022	us-gaap	Dividends Dividends	199000000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	321000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	954000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	570000000	usd
CY2023	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-588000000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	35000000	usd
CY2023	us-gaap	Dividends Dividends	209000000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	306000000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37000000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	533000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10334000000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	954000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-554000000	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-359000000	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	182000000	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5310000000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2664000000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5526000000	usd
CY2023	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-1801000000	usd
CY2022	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	2186000000	usd
CY2021	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-21000000	usd
CY2023	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3897000000	usd
CY2022	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3536000000	usd
CY2021	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3966000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-102000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	34000000	usd
CY2021	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-41000000	usd
CY2023	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	1145000000	usd
CY2022	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	866000000	usd
CY2021	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	832000000	usd
CY2023	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	528000000	usd
CY2022	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	530000000	usd
CY2021	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	553000000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	27000000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-11000000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-49000000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-207000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1547000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	739000000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	107000000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	131000000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	129000000	usd
CY2023	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-2000000	usd
CY2022	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	11000000	usd
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-55000000	usd
CY2023	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-622000000	usd
CY2022	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-601000000	usd
CY2021	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-519000000	usd
CY2023	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	20000000	usd
CY2022	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	73000000	usd
CY2021	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	626000000	usd
CY2023	jxn	Increase Decrease In Future Policy Benefits IncreaseDecreaseInFuturePolicyBenefits	731000000	usd
CY2022	jxn	Increase Decrease In Future Policy Benefits IncreaseDecreaseInFuturePolicyBenefits	1137000000	usd
CY2021	jxn	Increase Decrease In Future Policy Benefits IncreaseDecreaseInFuturePolicyBenefits	1102000000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-123000000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-305000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5310000000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-521000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5206000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5682000000	usd
CY2023	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	11488000000	usd
CY2022	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	11535000000	usd
CY2021	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	19568000000	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	316000000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	84000000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	50000000	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	2492000000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1695000000	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	1747000000	usd
CY2023	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	8231000000	usd
CY2022	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	11606000000	usd
CY2021	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	14733000000	usd
CY2023	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	200000000	usd
CY2022	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	249000000	usd
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	111000000	usd
CY2023	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1605000000	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1816000000	usd
CY2021	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	2427000000	usd
CY2023	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	5475000000	usd
CY2022	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	674000000	usd
CY2021	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	4836000000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-623000000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	343000000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	554000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-592000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1374000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1296000000	usd
CY2023	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	14189000000	usd
CY2022	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	18456000000	usd
CY2021	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	20134000000	usd
CY2023	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	29112000000	usd
CY2022	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	25173000000	usd
CY2021	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	28712000000	usd
CY2023	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	10017000000	usd
CY2022	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	5685000000	usd
CY2021	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2664000000	usd
CY2023	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	-1025000000	usd
CY2022	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	-541000000	usd
CY2021	jxn	Proceeds From Payments On Repurchase Agreements And Securities Lending ProceedsFromPaymentsOnRepurchaseAgreementsAndSecuritiesLending	476000000	usd
CY2023	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	-250000000	usd
CY2022	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	0	usd
CY2021	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	380000000	usd
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	750000000	usd
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	3943000000	usd
CY2023	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	603000000	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	825000000	usd
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1615000000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7000000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	28000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	297000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	351000000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	111000000	usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	92000000	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
CY2021	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
CY2023	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	0	usd
CY2022	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	0	usd
CY2021	jxn	Proceeds From Disposition Of Shares Held In Trust ProceedsFromDispositionOfSharesHeldInTrust	5000000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	201000000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	186000000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	50000000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	35000000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	306000000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	321000000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	211000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	533000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6328000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2162000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3774000000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1610000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1670000000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	612000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2019000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2691000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-21000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	183000000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	107000000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	30000000	usd
CY2023	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	144000000	usd
CY2022	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	506000000	usd
CY2021	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	370000000	usd
CY2023	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	317000000	usd
CY2022	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	112000000	usd
CY2021	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	99000000	usd
CY2023Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	8000000	usd
CY2022Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	13000000	usd
CY2021Q4	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2688000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2623000000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3000000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3000000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	8000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2691000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain amounts in the 2022 Notes to Consolidated Financial Statements have been reclassified to conform to the 2023 presentation.
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in these notes, include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assessments as to whether certain entities are VIEs, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions used in calculating policy reserves and liabilities including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions used in calculating market risk benefits, including policyholder behavior, mortality rates, and capital market assumptions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Assumptions impacting the expected term used in amortizing deferred acquisition costs, including policyholder behavior and mortality rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the Consolidated Financial Statements in the periods the estimates are changed.</span></div>
CY2021Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14043000000	usd
CY2021Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	35116000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	471000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	690000000	usd
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1882000000	usd
CY2021Q1	us-gaap	Other Assets OtherAssets	1181000000	usd
CY2021Q1	us-gaap	Assets Assets	355511000000	usd
CY2021Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	16796000000	usd
CY2021Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	63585000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	10690000000	usd
CY2021Q1	us-gaap	Liabilities Liabilities	348576000000	usd
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3436000000	usd
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2927000000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6935000000	usd
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355511000000	usd
CY2021Q1	jxn	Liability For Future Policy Benefit Expected Future Policy Benefit Before Other Future Policy Benefits And Claims Payable LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitBeforeOtherFuturePolicyBenefitsAndClaimsPayable	14022000000	usd
CY2021Q1	us-gaap	Liability For Future Policy Benefit After Reinsurance LiabilityForFuturePolicyBenefitAfterReinsurance	16796000000	usd
CY2021Q1	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	10000000000	usd
CY2021Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	14043000000	usd
CY2021Q1	us-gaap	Liability For Future Policy Benefit Reinsurance Recoverable After Allowance LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance	35116000000	usd
CY2021Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	471000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	12923000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	320000000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	944000000	usd
CY2023Q1	us-gaap	Assets Assets	314983000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	305605000000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3378000000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6403000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314983000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-837000000	usd
CY2023Q1	us-gaap	Revenues Revenues	9863000000	usd
CY2023Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	1062000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	34000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3536000000	usd
CY2023Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	866000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	1226000000	usd
CY2023Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2129000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7734000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1505000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6186000000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	72.34
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	69.75
CY2022Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-5365000000	usd
CY2022Q1	us-gaap	Revenues Revenues	6360000000	usd
CY2022Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	925000000	usd
CY2022Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-41000000	usd
CY2022Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3966000000	usd
CY2022Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	832000000	usd
CY2022Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	1307000000	usd
CY2022Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2015000000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4345000000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	666000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3417000000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	36.35
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	36.17
CY2023Q1	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7507000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	1303000000	usd
CY2023Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	1468000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4738000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1448000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2144000000	usd
CY2022Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	397000000	usd
CY2022Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	-332000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2076000000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1341000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	6229000000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2664000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3536000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	34000000	usd
CY2023Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	866000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1547000000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-601000000	usd
CY2023Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	73000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	832000000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1203000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5206000000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3679000000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-5526000000	usd
CY2022Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	3966000000	usd
CY2022Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-41000000	usd
CY2022Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	832000000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	739000000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-519000000	usd
CY2022Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	626000000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	581000000	usd
CY2022Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	2484000000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5682000000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023	us-gaap	Revenues Revenues	3159000000	usd
CY2022	us-gaap	Revenues Revenues	9863000000	usd
CY2021	us-gaap	Revenues Revenues	6360000000	usd
CY2023	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2201000000	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2129000000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2015000000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	938000000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	7691000000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	4083000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1505000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	666000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	934000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6186000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3417000000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	35000000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	899000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6186000000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3417000000	usd
CY2023Q4	us-gaap	Assets Assets	330255000000	usd
CY2022Q4	us-gaap	Assets Assets	314983000000	usd
CY2023Q4	jxn	Debt Securities Rated DebtSecuritiesRated	486000000	usd
CY2022Q4	jxn	Debt Securities Rated DebtSecuritiesRated	32000000	usd
CY2023Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2022Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2023Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	47065000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	21000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	259000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4660000000	usd
CY2023Q4	us-gaap	Debt Securities DebtSecurities	42643000000	usd
CY2022Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	51071000000	usd
CY2022Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	23000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	115000000	usd
CY2022Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6401000000	usd
CY2022Q4	us-gaap	Debt Securities DebtSecurities	44762000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne	3001000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	1000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	21000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne	2981000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	10030000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	10000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	40000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	280000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	9780000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	11657000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	5000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	102000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	974000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	10780000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	8626000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	0	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	80000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	1288000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	7418000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	6930000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	0	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	17000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	1588000000	usd
CY2023Q4	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	5359000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	47065000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	21000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	259000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4660000000	usd
CY2023Q4	us-gaap	Debt Securities DebtSecurities	42643000000	usd
CY2023Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	91000000	usd
CY2022Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	90000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	143000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	2776000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	385	security
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3571000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	30605000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	3786	security
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4517000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	30323000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	3695	security
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2830000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	8508000000	usd
CY2022Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	1056	security
CY2023Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	4660000000	usd
CY2023Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	33099000000	usd
CY2023Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	3968	security
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	6401000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	39113000000	usd
CY2022Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	4645	security
CY2022	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2023	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivable
CY2023	jxn	Debt Securities Available For Sale Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAccruedInterestAllowanceForCreditLossWriteoff	1000000	usd
CY2022	jxn	Debt Securities Available For Sale Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	60000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	4000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	2000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	30000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	34000000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	9000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	54000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-18000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	5000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	17000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	411000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	407000000	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	278000000	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	100000000	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	126000000	usd
CY2023	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	1756000000	usd
CY2022	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	1507000000	usd
CY2021	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	2236000000	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	2930000000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	2761000000	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	3424000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	22000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	41000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	169000000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	397000000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	429000000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	88000000	usd
CY2023	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	29000000	usd
CY2022	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	5000000	usd
CY2021	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	10000000	usd
CY2023	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	104000000	usd
CY2022	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	16000000	usd
CY2021	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	-62000000	usd
CY2023	jxn	Other Operating Gain Loss OtherOperatingGainLoss	-46000000	usd
CY2022	jxn	Other Operating Gain Loss OtherOperatingGainLoss	50000000	usd
CY2021	jxn	Other Operating Gain Loss OtherOperatingGainLoss	49000000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-554000000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-359000000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	182000000	usd
CY2023	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-5864000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-3023000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-5344000000	usd
CY2023	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-7665000000	usd
CY2022	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-837000000	usd
CY2021	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-5365000000	usd
CY2023	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	5529000000	usd
CY2022	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	5376000000	usd
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	2604000000	usd
CY2023	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.97
CY2022	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.93
CY2021	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.95
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6800000000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	8000000000.0	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	9600000000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	276000000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	97000000	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-97000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1140000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1453000000	usd
CY2023Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2576000000	usd
CY2022Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	3285000000	usd
CY2023	jxn	Interest And Principal Payment Deferral Repayment Period Covid19 InterestAndPrincipalPaymentDeferralRepaymentPeriodCOVID19	P1Y
CY2023Q4	jxn	Deferred Interest And Principal Payment Amount Covid19 DeferredInterestAndPrincipalPaymentAmountCOVID19	8000000	usd
CY2023	jxn	Financing Receivable Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag FinancingReceivableAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Consolidated Balance Sheets
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	66000000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	136000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	165000000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	94000000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	46000000	usd
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	48000000	usd
CY2023Q4	jxn	Financing Receivable90 Days Or More Past Due Still Accruing Writeoff FinancingReceivable90DaysOrMorePastDueStillAccruingWriteoff	2000000	usd
CY2022Q4	jxn	Financing Receivable90 Days Or More Past Due Still Accruing Writeoff FinancingReceivable90DaysOrMorePastDueStillAccruingWriteoff	0	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	24000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	15000000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	27000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	16000000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1000000	usd
CY2022Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	0	usd
CY2023	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	19000000	usd
CY2022	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	18000000	usd
CY2023	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	1000000	usd
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	879000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	855000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1408000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	4824000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10563000000	usd
CY2023Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	1315000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1927000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1260000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1554000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1511000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	3978000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2022Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2023Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	24000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10563000000	usd
CY2022Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	15000000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	11549000000	usd
CY2023Q4	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	19000000	usd
CY2022Q4	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	3000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3500000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3400000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	900000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	1000000000.0	usd
CY2023Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	19000000	usd
CY2022Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	35000000	usd
CY2023Q4	jxn	Securities Loaned Minimum Fair Value Collateral Percent SecuritiesLoanedMinimumFairValueCollateralPercent	1.02
CY2023Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	19000000	usd
CY2022Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	36000000	usd
CY2023	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	The following table presents information regarding these transactions for the December 31, 2023 and 2022 (in millions, except percentage data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"></td><td style="width:72.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.154%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.155%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Highest level of short-term borrowings at any month end</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,660 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,012 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Average short-term borrowing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Outstanding repurchase agreement balance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Collateralized with U.S. Treasury securities and corporate securities of nil and $1,056 million at December 31, 2023 and 2022, respectively, maturing within 30 days, and was included within repurchase agreements and securities lending payable in the Consolidated Balance Sheets.</span></div></td></tr></table>
CY2023	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	1660000000	usd
CY2022	jxn	Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding	1012000000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	970000000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	311000000	usd
CY2023	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0459
CY2022	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0254
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2023	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	0	usd
CY2022	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	1056000000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-4762000000	usd
CY2022Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	885000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	858000000	usd
CY2022Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	1680000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	1650000000	usd
CY2023Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	910000000	usd
CY2022Q4	jxn	Derivative Disbursement Obligation DerivativeDisbursementObligation	30000000	usd
CY2022Q4	jxn	Derivative Claim DerivativeClaim	27000000	usd
CY2022Q4	jxn	Derivative Asset Pledged Collateral DerivativeAssetPledgedCollateral	1641000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	390000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	390000000	usd
CY2023Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	108000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	9000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1210000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1210000000	usd
CY2023Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	6000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	744000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	187000000	usd
CY2023Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2023Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	1229000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	1229000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	25000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	744000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	187000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	683000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	157000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	45000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1638000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	42000000	usd
CY2022Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1012000000	usd
CY2022Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3113000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	385000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	36000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	2650000000	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	42000000	usd
CY2023Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	481000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	394000000	usd
CY2023Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	481000000	usd
CY2023Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	135000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3457000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	390000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2688000000	usd
CY2023Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	149000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	6737000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	276730000000	usd
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2090000000	usd
CY2023Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	1158000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1210000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	4785000000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11231000000	usd
CY2023Q4	us-gaap	Alternative Investment AlternativeInvestment	1997000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	393000000	usd
CY2022Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	582000000	usd
CY2022Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	440000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3419000000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1270000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4298000000	usd
CY2022Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	221000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	256156000000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1135000000	usd
CY2022Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	424000000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2065000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11018000000	usd
CY2022Q4	us-gaap	Alternative Investment AlternativeInvestment	2772000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	348000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	889000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	231000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	196000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-506000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	699000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	68000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	215000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	292000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	554000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	57000000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	1331000000	usd
CY2023	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Unobservable Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisUnobservableAssetTransfersOutOfLevel3	7000000	usd
CY2023	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Unobservable Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisUnobservableAssetTransfersIntoLevel3	18000000	usd
CY2023	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3	1336000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	5000000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	53000000	usd
CY2022	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Unobservable Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisUnobservableAssetTransfersIntoLevel3	9000000	usd
CY2022	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Unobservable Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisUnobservableAssetTransfersOutOfLevel3	0	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10082000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	942000000	usd
CY2023Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	108000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	33161000000	usd
CY2023Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	700000000	usd
CY2023Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5756000000	usd
CY2023Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	1950000000	usd
CY2023Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	18794000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2037000000	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	19000000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	250000000	usd
CY2023Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219656000000	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10967000000	usd
CY2022Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	958000000	usd
CY2022Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	146000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	36222000000	usd
CY2022Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	1128000000	usd
CY2022Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5887000000	usd
CY2022Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	2004000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	22533000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2022Q4	us-gaap	Securities Loaned SecuritiesLoaned	36000000	usd
CY2022Q4	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1012000000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	195906000000	usd
CY2023Q4	jxn	Federal Home Loan Bank Capital Stock Share Price FederalHomeLoanBankCapitalStockSharePrice	100
CY2023	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Acquisition Costs<div style="padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:0.18pt;padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as DAC in the period they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. DAC are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expected term used to amortize DAC is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, MRBs, and additional liabilities for applicable contracts. For amortization of DAC related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized DAC are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized DAC at the time of the replacement. </span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the roll-forward of the DAC (in millions). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"></td><td style="width:55.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Variable Annuities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Change in accounting principle</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">151 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">394</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">779 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,126)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,967</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,364 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Reconciliation of total DAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,967</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other product lines, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">335</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total balance, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.77pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,302</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,923 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,525 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See Note 2 - Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements for the transition to LDTI impact to the 2021 beginning of period balance for DAC.</span></div></td></tr></table></div>The assumptions used in the amortization of deferred acquisition costs consist of mortality and persistency. We have undertaken a comprehensive review of the assumptions used in the amortization of deferred acquisition costs, and there was no significant impact from changes to the mortality or persistency assumptions.
CY2023Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	335000000	usd
CY2022Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	224000000	usd
CY2021Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	161000000	usd
CY2023Q4	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12302000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12923000000	usd
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	13525000000	usd
CY2023	us-gaap	Direct Premiums Earned DirectPremiumsEarned	328000000	usd
CY2022	us-gaap	Direct Premiums Earned DirectPremiumsEarned	360000000	usd
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	407000000	usd
CY2023	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	35000000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	40000000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	usd
CY2023	us-gaap	Ceded Premiums Earned CededPremiumsEarned	216000000	usd
CY2022	us-gaap	Ceded Premiums Earned CededPremiumsEarned	268000000	usd
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	usd
CY2023	us-gaap	Premiums Earned Net PremiumsEarnedNet	147000000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	132000000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	148000000	usd
CY2023	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1582000000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1718000000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1500000000	usd
CY2023	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	802000000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	868000000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	880000000	usd
CY2023	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	831000000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	921000000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	830000000	usd
CY2023	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	588000000	usd
CY2022	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	603000000	usd
CY2021	jxn	Policyholder Benefits And Claims Incurred Changes In Reserves Net Of Reinsurance PolicyholderBenefitsAndClaimsIncurredChangesInReservesNetOfReinsurance	625000000	usd
CY2023	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	965000000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1062000000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	925000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	29000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	15000000	usd
CY2023Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	669000000	usd
CY2022Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	787000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	25422000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	29046000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	149000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	221000000	usd
CY2023Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	20226000000	usd
CY2022Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	23226000000	usd
CY2023Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	19952000000	usd
CY2022Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	22957000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	196000000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9299000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9637000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1446000000	usd
CY2022Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1550000000	usd
CY2023Q4	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	11898000000	usd
CY2022Q4	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	12318000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	363000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	400000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	394000000	usd
CY2022	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	420000000	usd
CY2023Q4	jxn	Funding Agreement FundingAgreement	2300000000	usd
CY2022Q4	jxn	Funding Agreement FundingAgreement	2100000000	usd
CY2023	jxn	Borrowings On Mortgage Related Securities And Commercial Mortgage Loans BorrowingsOnMortgageRelatedSecuritiesAndCommercialMortgageLoans	3500000000	usd
CY2022	jxn	Borrowings On Mortgage Related Securities And Commercial Mortgage Loans BorrowingsOnMortgageRelatedSecuritiesAndCommercialMortgageLoans	3100000000	usd
CY2023Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	55319000000	usd
CY2022Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	58190000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	220000000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	195906000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	6737000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	4865000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	4785000000	usd
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	5662000000	usd
CY2023Q4	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	-1952000000	usd
CY2022Q4	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	797000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2037000000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2635000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	648000000	usd
CY2023Q4	jxn	Long Term Debt Maturity Year Five And Thereafter LongTermDebtMaturityYearFiveAndThereafter	1389000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2037000000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	250000000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2023	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	7000000	usd
CY2022	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	0	usd
CY2021	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	6000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	263000000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	213000000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-43000000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-71000000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2000000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2000000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	211000000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-42000000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-73000000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-205000000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1489000000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	715000000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	58000000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	24000000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-207000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1547000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	739000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1505000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	666000000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	197000000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1615000000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	857000000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1000000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	47000000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	17000000	usd
CY2023	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	133000000	usd
CY2022	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	142000000	usd
CY2021	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	146000000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7000000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2000000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	48000000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	24000000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	46000000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4000000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	7000000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-16000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1505000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	666000000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.196
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.163
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-21000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-403000000	usd
CY2023	jxn	Income Tax Paid Refunded Excluding Interest IncomeTaxPaidRefundedExcludingInterest	-314000000	usd
CY2023	jxn	Income Tax Paid Refunded Interest IncomeTaxPaidRefundedInterest	-24000000	usd
CY2023	jxn	Income Tax Paid Refunded Refunds From Overpayment IncomeTaxPaidRefundedRefundsFromOverpayment	-73000000	usd
CY2023Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	1052000000	usd
CY2022Q4	jxn	Deferred Tax Assets Policy Reserves And Other Insurance Items DeferredTaxAssetsPolicyReservesAndOtherInsuranceItems	1645000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	140000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	165000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	870000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	789000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	374000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	51000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	952000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	1364000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	952000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	587000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	34000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	24000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4374000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4625000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	689000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	910000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3685000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3715000000	usd
CY2023Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2465000000	usd
CY2022Q4	jxn	Deferred Tax Liabilities Deferred Acquisition Costs And Sales Inducements DeferredTaxLiabilitiesDeferredAcquisitionCostsAndSalesInducements	2586000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	561000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	781000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	19000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	28000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3045000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3395000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	640000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	320000000	usd
CY2023Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	usd
CY2022Q4	jxn	Operating Loss Carryforward Acquisition OperatingLossCarryforwardAcquisition	137000000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	269000000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	6000000	usd
CY2023Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	5325000000	usd
CY2022Q4	jxn	Operating Loss And Tax Credit Carryforwards OperatingLossAndTaxCreditCarryforwards	3105000000	usd
CY2023Q4	jxn	Operating Loss Carryforwards Section382 Annual Limitation OperatingLossCarryforwardsSection382AnnualLimitation	21000000	usd
CY2023Q4	jxn	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	204000000	usd
CY2023Q4	jxn	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	358000000	usd
CY2023Q4	jxn	Tax Credit Carryforward Period TaxCreditCarryforwardPeriod	P10Y
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	263000000	usd
CY2023Q4	jxn	Tax Credit Carryforward Subject To Limitations Amount TaxCreditCarryforwardSubjectToLimitationsAmount	6000000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24000000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26000000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	32000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36000000	usd
CY2023	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	43000000	usd
CY2022	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	46000000	usd
CY2021	jxn	Lessee Operating Lease Net Lease Expense LesseeOperatingLeaseNetLeaseExpense	33000000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7000000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	7000000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8000000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	4000000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	3000000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	3000000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	4000000	usd
CY2023	us-gaap	Lease Cost LeaseCost	8000000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8000000	usd
CY2021	us-gaap	Lease Cost LeaseCost	8000000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	10000000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9000000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11000000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2000000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	4000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	36000000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	32000000	usd
CY2023	jxn	Share Based Compensation Arrangement By Share Based Payment Award Plan Term ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanTerm	P10Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	11000000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	107000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	131000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	129000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	25000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	29000000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	26000000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	49000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y18D
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1007000000	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	4700000000	usd
CY2022Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6000000000.0	usd
CY2023	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-122000000	usd
CY2022	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	3688000000	usd
CY2021	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	136000000	usd
CY2023	jxn	Defined Contribution Plan Eligibility Number Of Service Hours In Twelve Month Period DefinedContributionPlanEligibilityNumberOfServiceHoursInTwelveMonthPeriod	1000	h
CY2023	jxn	Defined Contribution Plan Requisite Service Period DefinedContributionPlanRequisiteServicePeriod	P12M
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	34000000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31000000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	32000000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	474000000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	469000000	usd
CY2023	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	58000000	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	-47000000	usd
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	54000000	usd
CY2023	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1022000000	usd
CY2022	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1010000000	usd
CY2021	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	1126000000	usd
CY2023	jxn	Other Commission Expense OtherCommissionExpense	720000000	usd
CY2022	jxn	Other Commission Expense OtherCommissionExpense	846000000	usd
CY2021	jxn	Other Commission Expense OtherCommissionExpense	1042000000	usd
CY2023	jxn	Sub Advisor Expenses SubAdvisorExpenses	311000000	usd
CY2022	jxn	Sub Advisor Expenses SubAdvisorExpenses	329000000	usd
CY2021	jxn	Sub Advisor Expenses SubAdvisorExpenses	389000000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	875000000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1078000000	usd
CY2023	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-511000000	usd
CY2022	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-628000000	usd
CY2021	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	-796000000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	2549000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2432000000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2839000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	1337000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-8296000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-1829000000	usd
CY2023	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	-187000000	usd
CY2022	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	1664000000	usd
CY2021	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	507000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1220000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-1875000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	424000000	usd
CY2023	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	-21000000	usd
CY2022	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	36000000	usd
CY2021	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	37000000	usd
CY2023	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	231000000	usd
CY2022	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	114000000	usd
CY2021	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	371000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	140000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-4607000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1338000000	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-430000000	usd
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	131000000	usd
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	738000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	570000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4738000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2076000000	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	594.44
CY2023Q3	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	500.00
CY2023Q4	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	500.00
CY2023Q4	jxn	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	450000000	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88685694	shares
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1650973	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	7646569	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	2472647	shares
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	6502524	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78660221	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.55
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.50
CY2023	us-gaap	Net Income Loss NetIncomeLoss	934000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6186000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3417000000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	35000000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	899000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6186000000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3417000000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81799820	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85513787	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93994520	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1777406	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3176913	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	470991	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83577226	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88690700	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94465511	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.99
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	72.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	36.35
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	69.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	36.17
CY2023Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Cost SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost	64998000000	usd
CY2023Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	60855000000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	24000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	22000	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78660221	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78660221	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82690098	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82690098	shares
CY2023Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	12302000000	usd
CY2023Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	11898000000	usd
CY2023Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	55319000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	12923000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	12318000000	usd
CY2022Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	58190000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	13525000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	15190000000	usd
CY2021Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	58721000000	usd
CY2023	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	147000000	usd
CY2023	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2930000000	usd
CY2023	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	1145000000	usd
CY2023	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	1152000000	usd
CY2023	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2549000000	usd
CY2022	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	132000000	usd
CY2022	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2761000000	usd
CY2022	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	866000000	usd
CY2022	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	1226000000	usd
CY2022	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2432000000	usd
CY2021	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	148000000	usd
CY2021	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	3424000000	usd
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Interest Credited On Other Contract Holder Funds SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationInterestCreditedOnOtherContractHolderFunds	832000000	usd
CY2021	jxn	Sec Schedule1216 Insurance Companies Supplementary Insurance Information Deferred Acquisition And Sales Inducements Amortization SECSchedule1216InsuranceCompaniesSupplementaryInsuranceInformationDeferredAcquisitionAndSalesInducementsAmortization	1307000000	usd
CY2021	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	2839000000	usd
CY2023Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	75239000000	usd
CY2023Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	40972000000	usd
CY2023Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	15545000000	usd
CY2023Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	49812000000	usd
CY2023Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.312
CY2023	us-gaap	Direct Premiums Earned DirectPremiumsEarned	328000000	usd
CY2023	us-gaap	Ceded Premiums Earned CededPremiumsEarned	216000000	usd
CY2023	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	35000000	usd
CY2023	us-gaap	Premiums Earned Net PremiumsEarnedNet	147000000	usd
CY2023	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.238
CY2022Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	86792000000	usd
CY2022Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	49007000000	usd
CY2022Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	15976000000	usd
CY2022Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	53761000000	usd
CY2022Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.297
CY2022	us-gaap	Direct Premiums Earned DirectPremiumsEarned	360000000	usd
CY2022	us-gaap	Ceded Premiums Earned CededPremiumsEarned	268000000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	40000000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	132000000	usd
CY2022	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.303
CY2021Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	105704000000	usd
CY2021Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	63548000000	usd
CY2021Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	16358000000	usd
CY2021Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	58514000000	usd
CY2021Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.280
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	407000000	usd
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	301000000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	42000000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	148000000	usd
CY2021	us-gaap	Premiums Percentage Assumed To Net PremiumsPercentageAssumedToNet	0.284
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1043000000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	12000000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	151000000	usd
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	904000000	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	117000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	947000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	21000000	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1043000000	usd

Files In Submission

Name	View Source	Status
0001822993-24-000009-index-headers.html	Edgar Link	pending
0001822993-24-000009-index.html	Edgar Link	pending
0001822993-24-000009.txt	Edgar Link	pending
0001822993-24-000009-xbrl.zip	Edgar Link	pending
exhibit211listofsubsidiari.htm	Edgar Link	pending
exhibit231auditorsconsent_.htm	Edgar Link	pending
exhibit311_fyx202310-k.htm	Edgar Link	pending
exhibit312_fyx202310-k.htm	Edgar Link	pending
exhibit321_fyx202310-k.htm	Edgar Link	pending
exhibit322_fyx202310-k.htm	Edgar Link	pending
exhibit47descriptionofsecu.htm	Edgar Link	pending
exhibit971jficompensationc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
jxn-20231231.htm	Edgar Link	pending
jxn-20231231.xsd	Edgar Link	pending
jxn-20231231_g1.jpg	Edgar Link	pending
jxn-20231231_g2.jpg	Edgar Link	pending
jxn-20231231_g3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
jxn-20231231_cal.xml	Edgar Link	unprocessable
jxn-20231231_def.xml	Edgar Link	unprocessable
jxn-20231231_lab.xml	Edgar Link	unprocessable
jxn-20231231_pre.xml	Edgar Link	unprocessable
jxn-20231231_htm.xml	Edgar Link	completed
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R153.htm	Edgar Link	pending
R154.htm	Edgar Link	pending
R155.htm	Edgar Link	pending
R156.htm	Edgar Link	pending
R157.htm	Edgar Link	pending
R158.htm	Edgar Link	pending
R159.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R160.htm	Edgar Link	pending
R161.htm	Edgar Link	pending
R162.htm	Edgar Link	pending
R163.htm	Edgar Link	pending
R164.htm	Edgar Link	pending
R165.htm	Edgar Link	pending
R166.htm	Edgar Link	pending
R167.htm	Edgar Link	pending
R168.htm	Edgar Link	pending
R169.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R170.htm	Edgar Link	pending
R171.htm	Edgar Link	pending
R172.htm	Edgar Link	pending
R173.htm	Edgar Link	pending
R174.htm	Edgar Link	pending
R175.htm	Edgar Link	pending
R176.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JXN
Jackson Financial Inc. Stock $jxn

2024 Q1 Form 10-K Financial Statement

#000182299324000009 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN Jackson Financial Inc. Stock $jxn

2024 Q1 Form 10-K Financial Statement

#000182299324000009 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN
Jackson Financial Inc. Stock $jxn